Based on the data provided, the Domestic General Government Health Expenditure in the Philippines is expected to increase steadily from 2024 to 2028. The values start at 9.63% of General Government Expenditure in 2024 and rise to 10.1% by 2028.
Year-on-year percentage variations are relatively small but positive, indicating a consistent growth pattern. Specifically, from 2024 to 2025, the increase is approximately 1.25%, and from 2025 to 2026, it rises by around 1.13%. Similar growth patterns are observed for the subsequent years up to 2028.
Looking at the average variation per year (CAGR) over the last five years, there is a consistent upward trend, suggesting robust government commitment to healthcare expenditure.
Future trends to watch for include potential impacts of economic changes, healthcare policy reforms, and external factors such as pandemics. Monitoring these factors will be crucial in understanding whether this upward trajectory in health expenditure will be sustained or if adjustments will be necessary.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...